Eco Animal Health Regulatory Approval
05 December 2016 - 6:00PM
UK Regulatory
TIDMEAH
ECO Animal Health Group plc
(AIM: EAH)
ECO RECEIVES BRAZILIAN MARKETING AUTHORISATION FOR AIVLOSIN®
WATER SOLUBLE GRANULES FOR SWINE
ECO Animal Health Group plc is pleased to announce that its
subsidiary ECO Animal Health do Brasil, has received a marketing
authorisation from the Brazilian Ministry of Agriculture, Livestock
and Supply (MAPA) for the use of Aivlosin® 625 mg/g water soluble
granules in swine.
Aivlosin®, ECO's patented antimicrobial, is used under
veterinary prescription for the treatment of a variety of
economically important respiratory and enteric (gut) diseases in
poultry and pigs.
This formulation of Aivlosin® will be marketed for the treatment
of ileitis (porcine proliferative enteropathy (PPE)), an enteric
disease of swine. Aivlosin® water soluble granules dissolve readily
in water providing a simple solution for the accurate and
simultaneous treatment of large numbers of animals. Importantly,
with global concerns about the use of antibiotics in production
animals, this new treatment with its low therapeutic dose rate and
short treatment duration meets antimicrobial stewardship
guidelines.
Peter Lawrence, Chairman of ECO, commented "This approval from
the Brazilian MAPA is very important in the development of
Aivlosin® for swine globally. Brazil is one of the world's leading
producers and exporters of pork and this new formulation will
enhance our ability to offer an expanded range of valuable
therapeutic tools to swine producers for both the domestic and
export markets ".
Contacts:
ECO Animal Health Group plc
Peter Lawrence 020 8336 6190
Marc Loomes 020 8447 6906
Spiro Financial
Anthony Spiro 020 8336 6196
Peel Hunt LLP (Nominated Adviser)
Dan Webster, Richard Brown, George Sellar 020 7418 8900
N+1 Singer (Joint Broker) 020 7496 3000
Mark Taylor, Brough Ransom
ECO Animal Health Group plc is a leader in the development,
registration and marketing of pharmaceutical products for animals.
Our products for these global growth markets promote well-being.
Our financial goals are achieved through the careful and
responsible application of science to generate value for our
shareholders.
View source version on businesswire.com:
http://www.businesswire.com/news/home/20161204005014/en/
This information is provided by Business Wire
(END) Dow Jones Newswires
December 05, 2016 02:00 ET (07:00 GMT)
Eco Animal Health (LSE:EAH)
Historical Stock Chart
From Apr 2024 to May 2024
Eco Animal Health (LSE:EAH)
Historical Stock Chart
From May 2023 to May 2024